Aspiriant, LLC Abbott Laboratories Transaction History

Aspiriant, LLC

$2.61 Billion
Q3 2024

A detailed history of Aspiriant, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Aspiriant, LLC holds 20,318 shares of ABT stock, worth $2.34 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

20,318

Previous 20,351 0.16%

Holding current value

$2.34 Million

Previous $2.11 Million 9.56%

% of portfolio

0.09%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$100.07 - $118.13 $3,302 - $3,898	-33 Reduced 0.16%	20,318 $2.32 Million
Q2 2024 Jul 15, 2024	SELL	$100.73 - $112.44 $75,748 - $84,554	-752 Reduced 3.56%	20,351 $2.11 Million
Q1 2024 Apr 15, 2024	SELL	$109.52 - $120.96 $19,604 - $21,651	-179 Reduced 0.84%	21,103 $2.4 Million
Q4 2023 Jan 26, 2024	SELL	$90.19 - $110.4 $26,876 - $32,899	-298 Reduced 1.38%	21,282 $2.34 Million
Q3 2023 Oct 17, 2023	SELL	$95.53 - $114.62 $58,846 - $70,605	-616 Reduced 2.78%	21,580 $2.09 Million
Q2 2023 Jul 19, 2023	BUY	$100.78 - $112.29 $310,402 - $345,853	3,080 Added 16.11%	22,196 $2.42 Million
Q1 2023 Apr 27, 2023	SELL	$96.86 - $114.01 $10,945 - $12,883	-113 Reduced 0.59%	19,116 $1.94 Million
Q4 2022 Jan 23, 2023	SELL	$95.06 - $111.52 $36,693 - $43,046	-386 Reduced 1.97%	19,229 $0
Q3 2022 Oct 28, 2022	BUY	$96.76 - $112.03 $43,058 - $49,853	445 Added 2.32%	19,615 $1.9 Million
Q2 2022 Jul 25, 2022	BUY	$102.07 - $123.37 $10,411 - $12,583	102 Added 0.53%	19,170 $2.09 Million
Q1 2022 May 06, 2022	SELL	$114.02 - $139.04 $87,567 - $106,782	-768 Reduced 3.87%	19,068 $2.26 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $211,535 - $259,013	1,831 Added 10.17%	19,836 $2.79 Million
Q3 2021 Oct 27, 2021	SELL	$116.66 - $129.06 $87,844 - $97,182	-753 Reduced 4.01%	18,005 $2.13 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $46,970 - $55,291	444 Added 2.42%	18,758 $2.17 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $82,065 - $96,685	-754 Reduced 3.95%	18,314 $2.19 Million
Q4 2020 Feb 01, 2021	SELL	$105.0 - $114.42 $439,320 - $478,733	-4,184 Reduced 17.99%	19,068 $2.09 Million
Q3 2020 Oct 29, 2020	BUY	$91.64 - $111.29 $233,682 - $283,789	2,550 Added 12.32%	23,252 $2.54 Million
Q2 2020 Aug 06, 2020	SELL	$76.57 - $98.0 $110,720 - $141,708	-1,446 Reduced 6.53%	20,702 $1.89 Million
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $78,148 - $114,273	-1,244 Reduced 5.32%	22,148 $1.75 Million
Q4 2019 Jan 27, 2020	SELL	$78.51 - $87.4 $99,001 - $110,211	-1,261 Reduced 5.11%	23,392 $2.03 Million
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $72,755 - $78,889	-889 Reduced 3.48%	24,653 $2.06 Million
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $96,274 - $112,285	-1,321 Reduced 4.92%	25,542 $2.15 Million
Q1 2019 May 03, 2019	SELL	$66.22 - $80.06 $312,690 - $378,043	-4,722 Reduced 14.95%	26,863 $2.15 Million
Q4 2018 Feb 04, 2019	SELL	$65.56 - $74.27 $32,583 - $36,912	-497 Reduced 1.55%	31,585 $2.29 Million
Q3 2018 Oct 26, 2018	SELL	$60.81 - $73.36 $158,288 - $190,956	-2,603 Reduced 7.5%	32,082 $2.35 Million
Q2 2018 Aug 07, 2018	BUY	$57.57 - $63.54 $4,548 - $5,019	79 Added 0.23%	34,685 $2.12 Million
Q1 2018 May 04, 2018	BUY	$56.27 - $63.62 $1.73 Million - $1.95 Million	30,711 Added 788.47%	34,606 $2.07 Million
Q4 2017 Jan 31, 2018	SELL	$53.68 - $57.47 $1.97 Million - $2.11 Million	-36,649 Reduced 90.39%	3,895 $222,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $1.95 Million - $2.17 Million	40,544	40,544 $2.16 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account